These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 6247313

  • 1. Enterobacter cloacae outer membrane permeability to ceftizoxime (FK 749) and five other new cephalosporin derivatives.
    Kojo H, Shigi Y, Nishida M.
    J Antibiot (Tokyo); 1980 Mar; 33(3):317-21. PubMed ID: 6247313
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula.
    Esposito S, Galante D, Barba D.
    Chemioterapia; 1986 Apr; 5(2):101-4. PubMed ID: 3518963
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.
    Kesado T, Watanabe K, Asahi Y, Isono M, Ueno K.
    Antimicrob Agents Chemother; 1984 Jan; 25(1):131-3. PubMed ID: 6322676
    [Abstract] [Full Text] [Related]

  • 7. Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities.
    Kamimura T, Matsumoto Y, Okada N, Mine Y, Nishida M, Goto S, Kuwahara S.
    Antimicrob Agents Chemother; 1979 Nov; 16(5):540-8. PubMed ID: 525994
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T, Takeda Y, Kotera K, Nishimura T, Takashima T, Hiromatsu K, Tabuki K, Fujimoto S, Kamiki T, Yoshizaki E, Yabuuchi E, Shimizu Y, Matsunaga K, Yamanaka K, Furuta I, Iimori M, Kodama J, Tanaka M, Maejima K, Nukina M, Takashima E, Takahashi M, Harikane O, Masutani T.
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
    Neu HC.
    Annu Rev Pharmacol Toxicol; 1982 Feb; 22():599-642. PubMed ID: 6282190
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of the new cephalosporins.
    Brogard JM, Comte F.
    Antibiot Chemother (1971); 1982 Feb; 31():145-210. PubMed ID: 6277241
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.